NCT07012278 St. John's Wort Oil for Wound Healing and Pain After Cesarean Section
| NCT ID | NCT07012278 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sakarya University |
| Condition | Wound Healing |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2025-06-25 |
| Primary Completion | 2025-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2025-06-25 with a primary completion date of 2025-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Cesarean section refers to the surgical procedure in which the fetus is delivered via an incision, typically performed when vaginal delivery is not possible due to high-risk conditions. In recent years, the rate of cesarean deliveries has increased significantly. The quality of treatment and care is crucial in ensuring proper surgical wound healing following cesarean birth. Various new methods and products have been developed for wound healing and care in recent years, some of which are derived from herbal sources. The limitations of pharmacological methods used in the postpartum period, such as treatment failure, concerns about potential harm to the mother and infant, adverse side effects, negative impact on breastfeeding, emergence of resistant microorganisms, and ineffectiveness of current antibiotics, have led individuals to seek alternative natural remedies. Hypericum perforatum (commonly known as St. John's Wort) is frequently used in the postpartum period due to its antimicrobial and antioxidant properties. This study aims to examine the effects of Hypericum perforatum on wound healing and pain in women following cesarean delivery.
Eligibility Criteria
Inclusion Criteria: * Volunteering to participate in the research, * Having had a cesarean section, * Her first cesarean section, * Being fluent in Turkish. Exclusion Criteria: * Not wanting to participate in the research, * The existence of a communication barrier.
Contact & Investigator
Bilge Nur Yıldırım Bayraktar, PhD
STUDY CHAIR
sakarya üniversity
Frequently Asked Questions
Who can join the NCT07012278 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 45 Years, studying Wound Healing. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07012278 currently recruiting?
Yes, NCT07012278 is actively recruiting participants. Contact the research team at bilgeyildirim41@gmail.com for enrollment information.
Where is the NCT07012278 trial being conducted?
This trial is being conducted at Sakarya, Turkey (Türkiye).
Who is sponsoring the NCT07012278 clinical trial?
NCT07012278 is sponsored by Sakarya University. The principal investigator is Bilge Nur Yıldırım Bayraktar, PhD at sakarya üniversity. The trial plans to enroll 80 participants.